HomeTechnologyFDA reverses surprise rejection of Moderna's mRNA flu vaccine

FDA reverses surprise rejection of Moderna's mRNA flu vaccine

TechnologyFebruary 18, 2026
1 min read
FDA reverses surprise rejection of Moderna's mRNA flu vaccine
Trump admin's vaccine chief overruled FDA scientists to initially reject the shot.

The Food and Drug Administration has reversed its shocking refusal to consider Moderna's mRNA flu vaccine for approval.

The refusal was revealed last week in a sharply worded press release from Moderna. Subsequent reporting found that the decision was made by political appointee Vinay Prasad, the Trump administration's top vaccine regulator, who overruled a team of agency scientists and a top career official in rejecting Moderna's application.

In an announcement Wednesday morning, Moderna said the FDA has now agreed to review its vaccine after the company held a formal (Type A) meeting with the FDA and proposed a change to the regulatory pathways used in the application.

Read full article

Comments

Source: Ars Technica

Share this article

Related Articles

We translated the Palantir manifesto for actual human beings
2026Apr 22

We translated the Palantir manifesto for actual human beings

Palantir CEO Alex Karp is a man in charge of one of the most important and frightening companies in the world. Karp's new book, cowritten with Nicholas Zamiska, is called The Technological Republic. A

Article1 min read
Read More
SpaceX cuts a deal to maybe buy Cursor for $60 billion
2026Apr 22

SpaceX cuts a deal to maybe buy Cursor for $60 billion

With an IPO looming for Elon Musk's SpaceX / xAI / X combo platter of companies, SpaceX has announced an odd arrangement to either acquire the automated programming platform Cursor for $60 billion or

Article1 min read
Read More